Zhujiang Hospital: Sepsis trials

The registry lists 12 Sepsis studies with Zhujiang Hospital as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 4No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Plasma Neprilysin for Predicting Sepsis Within 48 Hours in ICU Patients With Infection or Suspected InfectionNot yet recruitingNCT07796386
• Racecadotril for Organ Injury in Sepsis PatientsEnrolling by invitationNCT07454421Phase 1/2
• Detection of Sepsis Occurrence by Using Blood FluorescenceRecruitingNCT06745115
• Nasal and Gut Microbiota Combined Clinical Events Predicts the Prognosis of Septic PatientsRecruitingNCT05143736
• Validation of the Accuracy of a Novel POCT Dry Blood Gas Analyzer in Acute Care SettingsCompletedNCT06726473
• Improvement of Organ Function by Apigenin in Elderly Patients With SepsisCompletedNCT05999682Phase 1/2
• Effects of Dietary Fiber on Bone MetabolismStatus unknownNCT05623098
• Clinical Efficacy of Megadose Vitamin C in SepsisCompletedNCT05194189Phase 2
• Adjunctive Granisetron Therapy in Patients With Sepsis or Septic ShockCompletedNCT03924518Phase 2
• The Central Venous Catheter Related Complications in Critically Ill PatientsStatus unknownNCT03841240
• Efficacy and Safety of a Multicomponent Physical Therapy Program in Mechanically Ventilated Patient With SepsisStatus unknownNCT03406494Not applicable
• Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic ShockCompletedNCT03258684Not applicable